Increased Polymer Length of Oligopeptide-Substituted Polynorbornenes with LiCl
摘要:
The ring-opening metathesis polymerization (ROMP) reaction is extraordinarily useful for the preparation of a large variety of polymers. We report that the length (n = 25-50) of high-substituent-density oligopeptide polymers synthesized by ROMP is dramatically improved upon addition of LiCl to reduce polymer and oligopeptide aggregation. This methodology should significantly expand the variety of polymers that may be prepared by ROMP and be of general use with norbornyl oligopeptides of any sequence.
Optimization and Anti-Cancer Properties of Fluoromethylketones as Covalent Inhibitors for Ubiquitin C-Terminal Hydrolase L1
作者:Aaron D. Krabill、Hao Chen、Sajjad Hussain、Chad S. Hewitt、Ryan D. Imhoff、Christine S. Muli、Chittaranjan Das、Paul J. Galardy、Michael K. Wendt、Daniel P. Flaherty
DOI:10.3390/molecules26051227
日期:——
this end a study was carried out to fully characterize and optimize the irreversible covalent UCHL1 inhibitor VAEFMK. Structure-activity relationship studies identified modifications to improve activity versus the target and a full cellular characterization was carried out for the first time with this scaffold. The studies produced a new inhibitor, 34, with an IC50 value of 7.7 µM against UCHL1 and no
A Facile Synthetic Method to Prepare Fluorescently Labeled ROMP Polymers
作者:Kenny S. Roberts、Nicole S. Sampson
DOI:10.1021/ol048935y
日期:2004.9.1
To probe the activities of sperm ADAM protein (fertilin,6), we devised a general synthetic strategy to generate fluorescently labeled fertilinbeta oligopeptide polymers. Immunofluorescence studies with these polymers demonstrated that fertilinbeta polymers bind specifically to a protein receptor on the mouse egg plasma membrane.
(Substituted)acyl dipeptidyl inhibitors of the ICE/ced-3 family of cysteine proteases
申请人:Idun Pharmaceuticals, Inc.
公开号:US20030232788A1
公开(公告)日:2003-12-18
This invention is directed to novel (substituted)acyl dipeptidyl ICE/ced-3 family inhibitor compounds. The invention is also directed to pharmaceutical compositions containing these compounds, as well as the use of such compositions in the treatment of patients suffering inflammatory, autoimmune and neurodegenerative diseases, for the prevention of ischemic injury, and for the preservation of organs that are to undergo a transplantation procedure.
Increased Polymer Length of Oligopeptide-Substituted Polynorbornenes with LiCl
作者:Kenny S. Roberts、Nicole S. Sampson
DOI:10.1021/jo0265737
日期:2003.3.1
The ring-opening metathesis polymerization (ROMP) reaction is extraordinarily useful for the preparation of a large variety of polymers. We report that the length (n = 25-50) of high-substituent-density oligopeptide polymers synthesized by ROMP is dramatically improved upon addition of LiCl to reduce polymer and oligopeptide aggregation. This methodology should significantly expand the variety of polymers that may be prepared by ROMP and be of general use with norbornyl oligopeptides of any sequence.